Affiliation:
1. From the NMR Laboratory for Physiological Chemistry (L.N., J.S.I., I.P., R.T.), Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School; the Cardiovascular Division (B.H.L.), Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School; and the Department of Biochemistry and the Diabetes and Metabolism Unit (K.T.), Boston University School of Medicine, Boston, Mass.
Abstract
Glycolysis increases in hypertrophied hearts but the mechanisms are unknown. We studied the regulation of glycolysis in hearts with pressure-overload LV hypertrophy (LVH), a model that showed marked increases in the rates of glycolysis (by 2-fold) and insulin-independent glucose uptake (by 3-fold). Although the V
max
of the key glycolytic enzymes was unchanged in this model, concentrations of free ADP, free AMP, inorganic phosphate (P
i
), and fructose-2,6-bisphosphate (F-2,6-P
2
), all activators of the rate-limiting enzyme phosphofructokinase (PFK), were increased (up to 10-fold). Concentrations of the inhibitors of PFK, ATP, citrate, and H
+
were unaltered in LVH. Thus, our findings show that increased glucose entry and activation of the rate-limiting enzyme PFK both contribute to increased flux through the glycolytic pathway in hypertrophied hearts. Moreover, our results also suggest that these changes can be explained by increased intracellular free [ADP] and [AMP], due to decreased energy reserve in LVH, activating the AMP-activated protein kinase cascade. This, in turn, results in enhanced synthesis of F-2,6-P
2
and increased sarcolemma localization of glucose transporters, leading to coordinated increases in glucose transport and activation of PFK.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
194 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献